Abiopharma

News list

KEARNES LAURILEE 🟡 adjusted position in 0 shares (1 derivative) of Byrna Technologies Inc. (BYRN) Transaction Date: May 05, 2026 | Filing ID: 015670

Full text

News bot May 7, 2026, 9:24 p.m.
🔍 KEARNES LAURILEE (Executive)

Company: Byrna Technologies Inc. (BYRN)

Report Date: 2026-05-05
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 2,313
- Total shares sold: 2,313
Detailed Transactions and Holdings:
- Acquired 2,313 shares of Common stock (Direct)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,387.00 | transaction_form_type: 4 | Footnotes: F2, F1
- Sold 2,313 shares of Restricted Stock Unit (Derivative)
  Date: 2026-05-05 | Code: M | equity_swap_involved: 0 | shares_owned_after: 4,080.00 | transaction_form_type: 4 | Footnotes: F1, F1, F2, F2
Footnotes:
- F1: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. This transaction represents the settlement of 2,313 restricted stock units in shares of common stock upon vesting.
- F2: These restricted stock units vested on 5/4/26 and were settled on 5/5/26.